Patrick Melchior

High‐dose treatment for malignant rhabdoid tumor of the kidney: No evidence for improved survival—The Gesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH) experience

Rhoikos Furtwängler, Leo Kager, Patrick Melchior et al. · Pediatric Blood & Cancer · 2017 · 52 citations

Medicine, Oncology, Chemotherapy +15

The Impact of Individual In Vivo Repair of DNA Double-Strand Breaks on Oral Mucositis in Adjuvant Radiotherapy of Head-and-Neck Cancer

Jochen Fleckenstein, Martin Kühne, Katharina Seegmüller et al. · International Journal of Radiation Oncology*Biology*Physics · 2010 · 48 citations

Medicine, Oncology, Radiation Oncology +17

Randomized phase-III-trial of concurrent chemoradiation for locally advanced head and neck cancer comparing dose reduced radiotherapy with paclitaxel/cisplatin to standard radiotherapy with fluorouracil/cisplatin: The PacCis-trial

Rainer Fietkau, Markus Hecht, Benjamin Hofner et al. · Radiotherapy and Oncology · 2020 · 42 citations

Medicine, Oncology, Radiation Oncology +13

Imaging dose and secondary cancer risk in image-guided radiotherapy of pediatric patients

Yvonne Dzierma, Katharina Mikulla, Patrick Richter et al. · Radiation Oncology · 2018 · 41 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Outcome of patients with stage IV high-risk Wilms tumour treated according to the SIOP2001 protocol: A report of the SIOP Renal Tumour Study Group

Claudia Pasqualini, Rhoikos Furtwängler, Harm van Tinteren et al. · European Journal of Cancer · 2020 · 40 citations · Full text

Medicine, Oncology, Surgery +11